Soluble PD-1-based vaccine targeting MUC1 VNTR and survivin improves anti-tumor effect-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Soluble PD-1-based vaccine targeting MUC1 VNTR and survivin improves anti-tumor effect

Published:2018-08 Issue: Volume:200 Page:33-42
ISSN:0165-2478
Container-title:Immunology Letters
language:en
Short-container-title:Immunology Letters

Author:

Liu Chenlu,Lu Zhenzhen,Xie Yu,Guo Qianqian,Geng Fei,Sun Bo,Wu Hui,Yu Bin,Wu Jiaxin,Zhang Haihong,Yu Xianghui,Kong Wei

Funder

Specialized Research Fund for the National Natural Science Foundation of China

Jilin Province Science and Technology Program

Changchun city science and technology plan project

National Science, Technology Major Project of the Ministry of Science and Technology of China

Jilin province science and technology development plan project

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference32 articles.

1. Recent developments in the treatment of metastatic colorectal cancer;Loree;Ther. Adv. Med. Oncol.,2017

2. Cancer immunotherapy: the beginning of the end of cancer?;Farkona;BMC Med.,2016

3. CD8+ T cell efficacy in vaccination and disease;Appay;Nat. Med.,2008

4. Cross-presentation of cell-associated antigens by MHC class I in dendritic cell subsets;Gutierrez-Martinez;Front. Immunol.,2015

5. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay;Bevan;J. Exp. Med.,1976

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleic acid cancer vaccines targeting tumor related angiogenesis. Could mRNA vaccines constitute a game changer?;Frontiers in Immunology;2024-07-16

2. Serum sPD‐1 and sPD‐L1 as predictive biomarkers for HBsAg clearance in HBeAg‐negative CHB patients undergoing IFN‐based therapy;Alimentary Pharmacology & Therapeutics;2024-06-25

3. The XCL1-Mediated DNA Vaccine Targeting Type 1 Conventional Dendritic Cells Combined with Gemcitabine and Anti-PD1 Antibody Induces Potent Antitumor Immunity in a Mouse Lung Cancer Model;International Journal of Molecular Sciences;2024-02-04

4. Survivin in lung cancer: a potential target for therapy and prevention—a narrative review;Translational Lung Cancer Research;2024-02

5. Mucin1 as a potential molecule for cancer immunotherapy and targeted therapy;Journal of Cancer;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3